FDA Coronavirus (COVID-19) Update for April 1st, 2020
April 2, 2020
Silver Spring, MD – Last Wednesday, April 1st, 2020, the U.S. Food and Drug Administration (FDA) announced the following actions taken in its ongoing response effort to the Coronavirus (COVID-19) pandemic.
FDA-ARGOS SARS-CoV-2 Reference Grade Sequence Data Now Available: In response to the Coronavirus (COVID-19) pandemic, the FDA—in collaboration with the U.S. Centers for Disease Control and Prevention (CDC), the Biodefense and Emerging Infections Research Resources Repository (BEI Resources) and the Institute for Genome Sciences at the University of Maryland and the National Center for Biotechnology Information (NCBI)—developed quality-controlled, reference sequence data for the SARS-CoV-2 reference strain for the United States.
Coronavirus
American Stroke Association says Cocaine greatly increases Stroke Risk within 24 hours of use
March 3, 2014
San Diego, CA – Cocaine greatly increases stroke risk in young adults within 24 hours of use, much more than other risk factors according to research presented at the American Stroke Association’s International Stroke Conference 2014.
Cocaine users were six to seven times more likely to suffer an ischemic stroke within 24 hours of using the drug, and the effect existed across different ethnicities, researchers wrote.
Cocaine use increases stroke risk. (American Heart Association)
